SSI Investment Management Inc. Sells 58 Shares of UnitedHealth Group Incorporated (UNH)
SSI Investment Management Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,164 shares of the healthcare conglomerate’s stock after selling 58 shares during the quarter. SSI Investment Management Inc.’s holdings in UnitedHealth Group were worth $771,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in UNH. Harbour Capital Advisors LLC increased its position in shares of UnitedHealth Group by 18,383.4% in the second quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after acquiring an additional 2,503,090 shares during the last quarter. Jennison Associates LLC increased its position in shares of UnitedHealth Group by 180.4% in the second quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock valued at $417,660,000 after acquiring an additional 1,449,130 shares during the last quarter. State Street Corp increased its position in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after acquiring an additional 1,122,534 shares during the last quarter. BlackRock Inc. grew its holdings in UnitedHealth Group by 1.2% during the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after purchasing an additional 796,654 shares during the period. Finally, American Century Companies Inc. grew its holdings in UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after purchasing an additional 681,111 shares during the period. 85.71% of the stock is currently owned by institutional investors and hedge funds.
A number of research firms recently commented on UNH. Cowen and Company reiterated an “outperform” rating and set a $220.00 price target (up previously from $175.00) on shares of UnitedHealth Group in a report on Friday, August 11th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Morgan Stanley lifted their price target on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Oppenheimer Holdings, Inc. lifted their price target on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a report on Wednesday, October 18th. Finally, Cantor Fitzgerald reiterated a “buy” rating and set a $208.00 price target on shares of UnitedHealth Group in a report on Tuesday, October 17th. Three research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $216.65.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares in the company, valued at $38,755,268.75. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the transaction, the director now owns 60,834 shares of the company’s stock, valued at $12,135,774.66. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 57,606 shares of company stock valued at $11,433,133. Company insiders own 0.89% of the company’s stock.
UnitedHealth Group Incorporated (NYSE:UNH) opened at $211.22 on Thursday. UnitedHealth Group Incorporated has a 1 year low of $150.00 and a 1 year high of $213.93. The company has a market cap of $204,220.00, a P/E ratio of 21.90, a price-to-earnings-growth ratio of 1.56 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the previous year, the business earned $2.17 earnings per share. The company’s revenue was up 8.7% on a year-over-year basis. equities research analysts anticipate that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 34.09%.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.